Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and magnetic resonance imaging (MRI) software solutions company SyntheticMR (Linköping, Sweden) today announced the launch of Smart Quant Neuro 3D [1] – a major advance in objective

Sammanhang: ...Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and magnetic resonance imaging (MRI) software solutions company SyntheticMR (Linköping, Sweden) today announced the launch of Smart Quant Neuro 3D [1] – a major advance in objective decision support for diagnosis and therapy assessment of brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips is partnering with its customers to improve productivity and access to more sustainable healthcare....

Omnämnda platser: Royal Philips, Sweden, Linköping. Omnämnda personer: solutions company, Quant Neuro.

Hamlet BioPharma’s continued development of brain tumor therapy

Sammanhang: ...Hamlet BioPharma’s continued development of brain tumor therapy...

Omnämnda personer: Hamlet BioPharma.